{% extends 'chartbase.html' %} 
 {% load static %} 
 {% block content %}
<link rel="stylesheet" type="text/css" href="{% static 'css/detail.css' %}">
<div id="container">
<div id="graph">


<style>

</style>

<div id="fig_el229321407145547567365830068155"></div>
<script>
function mpld3_load_lib(url, callback){
  var s = document.createElement('script');
  s.src = url;
  s.async = true;
  s.onreadystatechange = s.onload = callback;
  s.onerror = function(){console.warn("failed to load library " + url);};
  document.getElementsByTagName("head")[0].appendChild(s);
}

if(typeof(mpld3) !== "undefined" && mpld3._mpld3IsLoaded){
   // already loaded: just create the figure
   !function(mpld3){
       
       mpld3.draw_figure("fig_el229321407145547567365830068155", {"width": 900.0, "height": 800.0, "axes": [{"bbox": [0.125, 0.10999999999999999, 0.775, 0.77], "xlim": [8.0, 26.0], "ylim": [9.25, 11.999999999999998], "xdomain": [8.0, 26.0], "ydomain": [9.25, 11.999999999999998], "xscale": "linear", "yscale": "linear", "axes": [{"position": "bottom", "nticks": 0, "tickvalues": [], "tickformat_formatter": "", "tickformat": "", "scale": "linear", "fontsize": null, "grid": {"gridOn": false}, "visible": true}, {"position": "left", "nticks": 0, "tickvalues": [], "tickformat_formatter": "", "tickformat": "", "scale": "linear", "fontsize": null, "grid": {"gridOn": false}, "visible": true}], "axesbg": "#FFFFFF", "axesbgalpha": null, "zoomable": true, "id": "el22932140714552982880", "lines": [{"data": "data01", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553296400", "color": "#F08080", "linewidth": 1.5, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}, {"data": "data02", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553298800", "color": "#F08080", "linewidth": 1.5, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}, {"data": "data03", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553265024", "color": "#000000", "linewidth": 1.0, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}], "paths": [{"data": "data04", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "Z"], "id": "el22932140714552981872", "dasharray": "none", "alpha": 1, "facecolor": "none", "edgecolor": "#0000FF", "edgewidth": 1.0, "zorder": 1}, {"data": "data05", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "L", "L", "L", "Z"], "id": "el22932140714553026112", "dasharray": "none", "alpha": 1, "facecolor": "#1F77B4", "edgecolor": "none", "edgewidth": 1.0, "zorder": 1}, {"data": "data06", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "C", "C", "C", "C", "C", "C", "C", "C", "Z"], "id": "el22932140714553351808", "dasharray": "none", "alpha": 1, "facecolor": "#1F77B4", "edgecolor": "none", "edgewidth": 1.0, "zorder": 1}, {"data": "data07", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "L", "L", "L", "Z"], "id": "el22932140714553295536", "dasharray": "none", "alpha": 1, "facecolor": "#F08080", "edgecolor": "#F08080", "edgewidth": 1.0, "zorder": 1}], "markers": [], "texts": [{"text": "Population", "position": [11.0, 10.6], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714552950112"}, {"text": "Head and Neck Squamous Cell Carcinoma", "position": [10.1, 10.45], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553076896"}, {"text": "Gender: All", "position": [10.1, 10.35], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553073776"}, {"text": "Healthy condition: No", "position": [10.1, 10.25], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553075408"}, {"text": "minAge: 18 Years", "position": [10.1, 10.149999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553075360"}, {"text": "maxAge: 85 Years", "position": [10.1, 10.049999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553026592"}, {"text": "N=60", "position": [14.3, 10.600000000000001], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553025440"}, {"text": "M=None (Open Label)", "position": [14.3, 10.0], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553351856"}, {"text": "N", "position": [16.099999999999998, 10.3], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553348160"}, {"text": "Experimental", "position": [11.1, 9.9], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553297552"}, {"text": "pembrolizumab+cisplatin + 5-fluorouracil(3000mg/m) ", "position": [17.5, 10.4], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714554329600"}, {"text": "Objective: Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC", "position": [10.0, 11.299999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553262960"}, {"text": "Title: Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC", "position": [10.0, 11.499999999999998], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 15.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553263824"}, {"text": "36 months required to complete", "position": [24.4, 9.600000000000001], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553266032"}, {"text": "Official Title: Safety and Efficacy of Pembrolizumab in Combination With Low-dose PF (Cisplatin and 5-Fluorouracil) as Neoadjuvant \nTreatment for Locally Advanced Head and Neck Squamous Cell Carcinoma: a Multi-center, Single-arm Clinical Study Trial", "position": [10.0, 9.5], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553185376"}], "collections": [], "images": [], "sharex": [], "sharey": []}], "data": {"data01": [[10.0, 9.9], [11.0, 9.9]], "data02": [[16.4, 10.3], [17.4, 10.3]], "data03": [[25.4, 9.700000000000001], [25.4, 10.9]], "data04": [[10.0, 10.0], [14.0, 10.0], [14.0, 10.6], [10.0, 10.6]], "data05": [[14.0, 10.350000000000001], [14.0, 10.25], [15.6, 10.25], [15.6, 10.15], [16.0, 10.3], [15.6, 10.450000000000001], [15.6, 10.350000000000001]], "data06": [[16.2, 10.100000000000001], [16.25304062, 10.100000000000001], [16.30391597415697, 10.121073261682353], [16.34142135623731, 10.158578643762691], [16.37892673831765, 10.19608402584303], [16.4, 10.24695938], [16.4, 10.3], [16.4, 10.353040620000002], [16.37892673831765, 10.403915974156972], [16.34142135623731, 10.44142135623731], [16.30391597415697, 10.478926738317648], [16.25304062, 10.5], [16.2, 10.5], [16.14695938, 10.5], [16.09608402584303, 10.478926738317648], [16.05857864376269, 10.44142135623731], [16.02107326168235, 10.403915974156972], [16.0, 10.353040620000002], [16.0, 10.3], [16.0, 10.24695938], [16.02107326168235, 10.19608402584303], [16.05857864376269, 10.158578643762691], [16.09608402584303, 10.121073261682353], [16.14695938, 10.100000000000001], [16.2, 10.100000000000001]], "data07": [[17.4, 10.305000000000001], [17.4, 10.295], [23.0, 10.295], [23.0, 10.285], [24.4, 10.3], [23.0, 10.315000000000001], [23.0, 10.305000000000001]]}, "id": "el22932140714554756736", "plugins": [{"type": "reset"}, {"type": "zoom", "button": true, "enabled": false}, {"type": "boxzoom", "button": true, "enabled": false}]});
   }(mpld3);
}else if(typeof define === "function" && define.amd){
   // require.js is available: use it to load d3/mpld3
   require.config({paths: {d3: "https://d3js.org/d3.v5"}});
   require(["d3"], function(d3){
      window.d3 = d3;
      mpld3_load_lib("https://mpld3.github.io/js/mpld3.v0.5.8.js", function(){
         
         mpld3.draw_figure("fig_el229321407145547567365830068155", {"width": 900.0, "height": 800.0, "axes": [{"bbox": [0.125, 0.10999999999999999, 0.775, 0.77], "xlim": [8.0, 26.0], "ylim": [9.25, 11.999999999999998], "xdomain": [8.0, 26.0], "ydomain": [9.25, 11.999999999999998], "xscale": "linear", "yscale": "linear", "axes": [{"position": "bottom", "nticks": 0, "tickvalues": [], "tickformat_formatter": "", "tickformat": "", "scale": "linear", "fontsize": null, "grid": {"gridOn": false}, "visible": true}, {"position": "left", "nticks": 0, "tickvalues": [], "tickformat_formatter": "", "tickformat": "", "scale": "linear", "fontsize": null, "grid": {"gridOn": false}, "visible": true}], "axesbg": "#FFFFFF", "axesbgalpha": null, "zoomable": true, "id": "el22932140714552982880", "lines": [{"data": "data01", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553296400", "color": "#F08080", "linewidth": 1.5, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}, {"data": "data02", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553298800", "color": "#F08080", "linewidth": 1.5, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}, {"data": "data03", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553265024", "color": "#000000", "linewidth": 1.0, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}], "paths": [{"data": "data04", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "Z"], "id": "el22932140714552981872", "dasharray": "none", "alpha": 1, "facecolor": "none", "edgecolor": "#0000FF", "edgewidth": 1.0, "zorder": 1}, {"data": "data05", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "L", "L", "L", "Z"], "id": "el22932140714553026112", "dasharray": "none", "alpha": 1, "facecolor": "#1F77B4", "edgecolor": "none", "edgewidth": 1.0, "zorder": 1}, {"data": "data06", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "C", "C", "C", "C", "C", "C", "C", "C", "Z"], "id": "el22932140714553351808", "dasharray": "none", "alpha": 1, "facecolor": "#1F77B4", "edgecolor": "none", "edgewidth": 1.0, "zorder": 1}, {"data": "data07", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "L", "L", "L", "Z"], "id": "el22932140714553295536", "dasharray": "none", "alpha": 1, "facecolor": "#F08080", "edgecolor": "#F08080", "edgewidth": 1.0, "zorder": 1}], "markers": [], "texts": [{"text": "Population", "position": [11.0, 10.6], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714552950112"}, {"text": "Head and Neck Squamous Cell Carcinoma", "position": [10.1, 10.45], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553076896"}, {"text": "Gender: All", "position": [10.1, 10.35], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553073776"}, {"text": "Healthy condition: No", "position": [10.1, 10.25], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553075408"}, {"text": "minAge: 18 Years", "position": [10.1, 10.149999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553075360"}, {"text": "maxAge: 85 Years", "position": [10.1, 10.049999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553026592"}, {"text": "N=60", "position": [14.3, 10.600000000000001], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553025440"}, {"text": "M=None (Open Label)", "position": [14.3, 10.0], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553351856"}, {"text": "N", "position": [16.099999999999998, 10.3], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553348160"}, {"text": "Experimental", "position": [11.1, 9.9], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553297552"}, {"text": "pembrolizumab+cisplatin + 5-fluorouracil(3000mg/m) ", "position": [17.5, 10.4], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714554329600"}, {"text": "Objective: Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC", "position": [10.0, 11.299999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553262960"}, {"text": "Title: Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC", "position": [10.0, 11.499999999999998], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 15.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553263824"}, {"text": "36 months required to complete", "position": [24.4, 9.600000000000001], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553266032"}, {"text": "Official Title: Safety and Efficacy of Pembrolizumab in Combination With Low-dose PF (Cisplatin and 5-Fluorouracil) as Neoadjuvant \nTreatment for Locally Advanced Head and Neck Squamous Cell Carcinoma: a Multi-center, Single-arm Clinical Study Trial", "position": [10.0, 9.5], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553185376"}], "collections": [], "images": [], "sharex": [], "sharey": []}], "data": {"data01": [[10.0, 9.9], [11.0, 9.9]], "data02": [[16.4, 10.3], [17.4, 10.3]], "data03": [[25.4, 9.700000000000001], [25.4, 10.9]], "data04": [[10.0, 10.0], [14.0, 10.0], [14.0, 10.6], [10.0, 10.6]], "data05": [[14.0, 10.350000000000001], [14.0, 10.25], [15.6, 10.25], [15.6, 10.15], [16.0, 10.3], [15.6, 10.450000000000001], [15.6, 10.350000000000001]], "data06": [[16.2, 10.100000000000001], [16.25304062, 10.100000000000001], [16.30391597415697, 10.121073261682353], [16.34142135623731, 10.158578643762691], [16.37892673831765, 10.19608402584303], [16.4, 10.24695938], [16.4, 10.3], [16.4, 10.353040620000002], [16.37892673831765, 10.403915974156972], [16.34142135623731, 10.44142135623731], [16.30391597415697, 10.478926738317648], [16.25304062, 10.5], [16.2, 10.5], [16.14695938, 10.5], [16.09608402584303, 10.478926738317648], [16.05857864376269, 10.44142135623731], [16.02107326168235, 10.403915974156972], [16.0, 10.353040620000002], [16.0, 10.3], [16.0, 10.24695938], [16.02107326168235, 10.19608402584303], [16.05857864376269, 10.158578643762691], [16.09608402584303, 10.121073261682353], [16.14695938, 10.100000000000001], [16.2, 10.100000000000001]], "data07": [[17.4, 10.305000000000001], [17.4, 10.295], [23.0, 10.295], [23.0, 10.285], [24.4, 10.3], [23.0, 10.315000000000001], [23.0, 10.305000000000001]]}, "id": "el22932140714554756736", "plugins": [{"type": "reset"}, {"type": "zoom", "button": true, "enabled": false}, {"type": "boxzoom", "button": true, "enabled": false}]});
      });
    });
}else{
    // require.js not available: dynamically load d3 & mpld3
    mpld3_load_lib("https://d3js.org/d3.v5.js", function(){
         mpld3_load_lib("https://mpld3.github.io/js/mpld3.v0.5.8.js", function(){
                 
                 mpld3.draw_figure("fig_el229321407145547567365830068155", {"width": 900.0, "height": 800.0, "axes": [{"bbox": [0.125, 0.10999999999999999, 0.775, 0.77], "xlim": [8.0, 26.0], "ylim": [9.25, 11.999999999999998], "xdomain": [8.0, 26.0], "ydomain": [9.25, 11.999999999999998], "xscale": "linear", "yscale": "linear", "axes": [{"position": "bottom", "nticks": 0, "tickvalues": [], "tickformat_formatter": "", "tickformat": "", "scale": "linear", "fontsize": null, "grid": {"gridOn": false}, "visible": true}, {"position": "left", "nticks": 0, "tickvalues": [], "tickformat_formatter": "", "tickformat": "", "scale": "linear", "fontsize": null, "grid": {"gridOn": false}, "visible": true}], "axesbg": "#FFFFFF", "axesbgalpha": null, "zoomable": true, "id": "el22932140714552982880", "lines": [{"data": "data01", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553296400", "color": "#F08080", "linewidth": 1.5, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}, {"data": "data02", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553298800", "color": "#F08080", "linewidth": 1.5, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}, {"data": "data03", "xindex": 0, "yindex": 1, "coordinates": "data", "id": "el22932140714553265024", "color": "#000000", "linewidth": 1.0, "dasharray": "none", "alpha": 1, "zorder": 2, "drawstyle": "default"}], "paths": [{"data": "data04", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "Z"], "id": "el22932140714552981872", "dasharray": "none", "alpha": 1, "facecolor": "none", "edgecolor": "#0000FF", "edgewidth": 1.0, "zorder": 1}, {"data": "data05", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "L", "L", "L", "Z"], "id": "el22932140714553026112", "dasharray": "none", "alpha": 1, "facecolor": "#1F77B4", "edgecolor": "none", "edgewidth": 1.0, "zorder": 1}, {"data": "data06", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "C", "C", "C", "C", "C", "C", "C", "C", "Z"], "id": "el22932140714553351808", "dasharray": "none", "alpha": 1, "facecolor": "#1F77B4", "edgecolor": "none", "edgewidth": 1.0, "zorder": 1}, {"data": "data07", "xindex": 0, "yindex": 1, "coordinates": "data", "pathcodes": ["M", "L", "L", "L", "L", "L", "L", "Z"], "id": "el22932140714553295536", "dasharray": "none", "alpha": 1, "facecolor": "#F08080", "edgecolor": "#F08080", "edgewidth": 1.0, "zorder": 1}], "markers": [], "texts": [{"text": "Population", "position": [11.0, 10.6], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714552950112"}, {"text": "Head and Neck Squamous Cell Carcinoma", "position": [10.1, 10.45], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553076896"}, {"text": "Gender: All", "position": [10.1, 10.35], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553073776"}, {"text": "Healthy condition: No", "position": [10.1, 10.25], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553075408"}, {"text": "minAge: 18 Years", "position": [10.1, 10.149999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553075360"}, {"text": "maxAge: 85 Years", "position": [10.1, 10.049999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553026592"}, {"text": "N=60", "position": [14.3, 10.600000000000001], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553025440"}, {"text": "M=None (Open Label)", "position": [14.3, 10.0], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553351856"}, {"text": "N", "position": [16.099999999999998, 10.3], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553348160"}, {"text": "Experimental", "position": [11.1, 9.9], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553297552"}, {"text": "pembrolizumab+cisplatin + 5-fluorouracil(3000mg/m) ", "position": [17.5, 10.4], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714554329600"}, {"text": "Objective: Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC", "position": [10.0, 11.299999999999999], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553262960"}, {"text": "Title: Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC", "position": [10.0, 11.499999999999998], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 15.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553263824"}, {"text": "36 months required to complete", "position": [24.4, 9.600000000000001], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553266032"}, {"text": "Official Title: Safety and Efficacy of Pembrolizumab in Combination With Low-dose PF (Cisplatin and 5-Fluorouracil) as Neoadjuvant \nTreatment for Locally Advanced Head and Neck Squamous Cell Carcinoma: a Multi-center, Single-arm Clinical Study Trial", "position": [10.0, 9.5], "coordinates": "data", "h_anchor": "start", "v_baseline": "auto", "rotation": -0.0, "fontsize": 10.0, "color": "#000000", "alpha": 1, "zorder": 3, "id": "el22932140714553185376"}], "collections": [], "images": [], "sharex": [], "sharey": []}], "data": {"data01": [[10.0, 9.9], [11.0, 9.9]], "data02": [[16.4, 10.3], [17.4, 10.3]], "data03": [[25.4, 9.700000000000001], [25.4, 10.9]], "data04": [[10.0, 10.0], [14.0, 10.0], [14.0, 10.6], [10.0, 10.6]], "data05": [[14.0, 10.350000000000001], [14.0, 10.25], [15.6, 10.25], [15.6, 10.15], [16.0, 10.3], [15.6, 10.450000000000001], [15.6, 10.350000000000001]], "data06": [[16.2, 10.100000000000001], [16.25304062, 10.100000000000001], [16.30391597415697, 10.121073261682353], [16.34142135623731, 10.158578643762691], [16.37892673831765, 10.19608402584303], [16.4, 10.24695938], [16.4, 10.3], [16.4, 10.353040620000002], [16.37892673831765, 10.403915974156972], [16.34142135623731, 10.44142135623731], [16.30391597415697, 10.478926738317648], [16.25304062, 10.5], [16.2, 10.5], [16.14695938, 10.5], [16.09608402584303, 10.478926738317648], [16.05857864376269, 10.44142135623731], [16.02107326168235, 10.403915974156972], [16.0, 10.353040620000002], [16.0, 10.3], [16.0, 10.24695938], [16.02107326168235, 10.19608402584303], [16.05857864376269, 10.158578643762691], [16.09608402584303, 10.121073261682353], [16.14695938, 10.100000000000001], [16.2, 10.100000000000001]], "data07": [[17.4, 10.305000000000001], [17.4, 10.295], [23.0, 10.295], [23.0, 10.285], [24.4, 10.3], [23.0, 10.315000000000001], [23.0, 10.305000000000001]]}, "id": "el22932140714554756736", "plugins": [{"type": "reset"}, {"type": "zoom", "button": true, "enabled": false}, {"type": "boxzoom", "button": true, "enabled": false}]});
            })
         });
}
</script></div>
<link rel="stylesheet" href="../static/css/trial-record.css">

<link rel="stylesheet" href="../static/css/w3-ct.css">

<link rel="stylesheet" href="../static/css/print.css">
<div id="trial">
<div id="main-content" tabindex="-1">
<div class="tr-indent2">
<h1 class="tr-h1 ct-sans-serif tr-solo_record">Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC</h1>
<div class="w3-row">
<div class="w3-col m6"> <div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;">
<table>
<tr>
<td style="width:5%">
<img alt="" src="/ct2/html/images/warning.png" style="width:1.3em;"/>
</td>
<td style="padding-right:2em;">
              The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
                              <a href="/ct2/about-studies/learn#Considerations">Know the risks and potential benefits</a> of clinical studies and talk to your health care provider before participating.
                            Read our <a href="/ct2/about-site/disclaimer">disclaimer</a> for details.
            </td>
</tr>
</table>
</div> </div>
<!--
  <div style="float:right;margin-right:4em">ClinicalTrials.gov Identifier: NCT05446467</div>
-->
<div class="w3-col m1"> </div>
<div class="w3-col m5"> <table style="width:95%">
<tr><td>ClinicalTrials.gov Identifier: NCT05446467</td>
</tr>
<tr><td>
<div class="tr-status tr-recruiting-colors">
<span class="term" data-term="Recruitment Status" style="display:inline;" title="Show definition">Recruitment Status <i aria-hidden="true" class="fa fa-info-circle term" data-term="Recruitment Status" style="border-bottom-style:none;"></i></span> : 
                    Not yet recruiting
                          
                
  <div style="font-size:inherit">
<span class="term" data-term="First Posted" style="display:inline;" title="Show definition">First Posted <i aria-hidden="true" class="fa fa-info-circle term" data-term="First Posted" style="border-bottom-style:none;"></i></span> : July 6, 2022</div>
<div style="font-size:inherit">
<span class="term" data-term="Last Update Posted" style="display:inline;" title="Show definition">Last Update Posted <i aria-hidden="true" class="fa fa-info-circle term" data-term="Last Update Posted" style="border-bottom-style:none;"></i></span> : July 6, 2022</div>
<div style="margin-top:1ex; font-size:14px">
<span style="color:black;">See </span><a href="#contacts">
<span class="ct-header2" style="font-size:inherit;"> Contacts and Locations</span></a>
</div>
</div>
</td>
</tr>
</table>
</div>
</div>
<div class="tr-info-title">Sponsor:</div>
<div class="tr-info-text" id="sponsor"> Zhejiang Provincial People's Hospital </div>
<div class="tr-info-title">Information provided by (Responsible Party):</div>
<div class="tr-info-text" id="responsibleparty">Minghua Ge, Zhejiang Provincial People's Hospital</div>
</div>
<br/>
<div id="tabs">
<ul id="tab-links">
<li class="current" id="full-text">Study Details     </li>
<li id="tabular"><a href="/ct2/show/record/NCT05446467">Tabular View</a></li>
<li id="results"><a href="/ct2/show/results/NCT05446467">No Results Posted</a></li>
<li id="disclaimer"><a href="/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false" title="Disclaimer - opens new window">Disclaimer</a></li>
<li id="howtoread"><a href="/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false" title="How to Read a Study Record - opens new window">How to Read a Study Record</a></li>
</ul>
</div> <!--
<div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"> </div>
-->
<div id="tab-body">
<div class="tr-indent2" style="background-color:white;">
<!-- purpose_section -->
<div class="tr-indent1" style="margin-top:1ex">
<div class="tr-subsection">
<div class="ct-header2"><a id="studydesc"></a>Study Description</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Go to 
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="#wrapper">Top of Page</a>
<a href="#studydesc">Study Description</a>
<a href="#studydesign">Study Design</a>
<!-- arms and groups table -->
<a href="#armgroup">Arms and Interventions</a>
<a href="#outcomemeasures">Outcome Measures</a>
<a href="#eligibility">Eligibility Criteria</a>
<a href="#contactlocation">Contacts and Locations</a>
<a href="#moreinfo">More Information</a>
</div>
</div>
</div>
<div class="tr-indent2" style="margin-top:2ex">
<div class="ct-body3">Brief Summary:</div>
<div class="ct-body3 tr-indent2">A phase Ⅱ open label multi-cencter clinical trail to evaluate the efficacy and safety of pembrolizumab combined with low-dose PF (cisplatin + 5-fluorouracil) in the neoadjuvant treatment of locally advanced head and neck squamous cell carcinoma</div><br/>
<!-- condition, intervention, phase summary table -->
<table border="1" class="ct-data_table tr-data_table" style="margin:auto;width:80%;">
<tr style="text-align:left;">
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="Condition/disease" style="display:inline;" title="Show definition">Condition or disease <i aria-hidden="true" class="fa fa-info-circle term" data-term="Condition/disease" style="border-bottom-style:none;"></i></span> </th>
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="Intervention/treatment" style="display:inline;" title="Show definition">Intervention/treatment <i aria-hidden="true" class="fa fa-info-circle term" data-term="Intervention/treatment" style="border-bottom-style:none;"></i></span> </th>
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="Phase" style="display:inline;" title="Show definition">Phase <i aria-hidden="true" class="fa fa-info-circle term" data-term="Phase" style="border-bottom-style:none;"></i></span> </th>
</tr>
<tr style="text-align:left;vertical-align:top;">
<td class="ct-body3">
<span style="display:block;margin-bottom:1ex;">Head and Neck Squamous Cell Carcinoma</span>
</td>
<td class="ct-body3">
<span style="display:block;margin-bottom:1ex;">Drug: pembrolizumab+cisplatin + 5-fluorouracil</span>
</td>
<td class="ct-body3" style="white-space:nowrap;">
<span style="display:block;margin-bottom:1ex;">Phase 2</span>
</td>
</tr>
</table>
<br/>
<a id="desc"></a>
<!-- detailed description -->
<div class="COLLAPSE" id="COLLAPSE-DetailedDesc" style="margin-bottom:2ex;">
<div class="ct-body3"><a id="detaileddesc"></a>Detailed Description:</div>
<div class="ct-body3 tr-indent2">we designed a multi-center, single-arm, small sample clinical pilot study. In the clinical trial, patients were given regimes of induction therapy with PLPF (Pembrolizumab + Low dose- P (Platinum) F (5-Fluorouracil)): 6 cycles of Pembrolizumab treatment. Herein, we describe eight consecutive unselected LA SCCHN (Locally Advanced Head and Neck Squamous Cell Carcinoma) patients based on 6 completed cycles of PLPF induction therapy.</div>
</div>
</div>
<div class="tr-subsection">
<div class="ct-header2"><a id="studydesign"></a>Study Design</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Go to 
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="#wrapper">Top of Page</a>
<a href="#studydesc">Study Description</a>
<a href="#studydesign">Study Design</a>
<!-- arms and groups table -->
<a href="#armgroup">Arms and Interventions</a>
<a href="#outcomemeasures">Outcome Measures</a>
<a href="#eligibility">Eligibility Criteria</a>
<a href="#contactlocation">Contacts and Locations</a>
<a href="#moreinfo">More Information</a>
</div>
</div>
</div>
<p>
</p><table class="ct-layout_table tr-tableStyle tr-studyInfo" style="margin-bottom:2ex;">
<caption>Layout table for study information</caption>
<thead>
<tr>
<th id="studyInfoColTitle"></th>
<th id="studyInfoColData"></th>
</tr>
</thead>
<tbody>
<tr>
<td headers="studyInfoColTitle">
<span class="term" data-term="Study Type" style="display:inline;" title="Show definition">Study Type <i aria-hidden="true" class="fa fa-info-circle term" data-term="Study Type" style="border-bottom-style:none;"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">
        Interventional
                 (Clinical Trial)
                
        
      </td>
</tr>
<tr>
<td headers="studyInfoColTitle">Estimated
<span class="term" data-term="Enrollment" style="display:inline;" title="Show definition">Enrollment <i aria-hidden="true" class="fa fa-info-circle term" data-term="Enrollment" style="border-bottom-style:none;"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">60 participants</td>
</tr>
<tr>
<td headers="studyInfoColTitle">Allocation:</td>
<td headers="studyInfoColData" style="padding-left:1em">N/A</td>
</tr>
<tr>
<td headers="studyInfoColTitle">Intervention Model:</td>
<td headers="studyInfoColData" style="padding-left:1em">Single Group Assignment</td>
</tr>
<tr>
<td headers="studyInfoColTitle">Masking:</td>
<td headers="studyInfoColData" style="padding-left:1em"> None (Open Label)</td>
</tr>
<tr>
<td headers="studyInfoColTitle">Primary Purpose:</td>
<td headers="studyInfoColData" style="padding-left:1em"> Treatment</td>
</tr>
<tr>
<!--
      <td headers="studyInfoColTitle" style="padding-top:2ex;">Official Title:</td>
-->
<td headers="studyInfoColTitle">Official Title:</td>
<td headers="studyInfoColData" style="padding-left:1em;">Safety and Efficacy of Pembrolizumab in Combination With Low-dose PF (Cisplatin and 5-Fluorouracil) as Neoadjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma: a Multi-center, Single-arm Clinical Study Trial</td>
</tr>
<tr>
<td headers="studyInfoColTitle">  Estimated <span class="term" data-term="Study Start Date" style="display:inline;" title="Show definition">Study Start Date <i aria-hidden="true" class="fa fa-info-circle term" data-term="Study Start Date" style="border-bottom-style:none;"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">August 15, 2022</td>
</tr>
<tr>
<td headers="studyInfoColTitle">  Estimated <span class="term" data-term="Primary Completion Date" style="display:inline;" title="Show definition">Primary Completion Date <i aria-hidden="true" class="fa fa-info-circle term" data-term="Primary Completion Date" style="border-bottom-style:none;"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">May 1, 2024</td>
</tr>
<tr>
<td headers="studyInfoColTitle">  Estimated <span class="term" data-term="Study Completion Date" style="display:inline;" title="Show definition">Study Completion Date <i aria-hidden="true" class="fa fa-info-circle term" data-term="Study Completion Date" style="border-bottom-style:none;"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">August 1, 2025</td>
</tr>
</tbody>
</table>
<!-- NLM links -->
<p>
</p><div class="tr-indent2">
<div class="usa-alert usa-alert-warning nlm-info">
<strong>Resource links provided by the National Library of Medicine</strong>
<img alt="" src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;"/>
<p>
</p><p>
<!-- ghr links -->
</p><div style="margin-bottom:2ex">
<a class="tr-study-link" href="https://medlineplus.gov/genetics/" onclick="openNewWindow('https://medlineplus.gov/genetics/'); return false" title="MedlinePlus Genetics">MedlinePlus Genetics</a> related topics:
    	    	    	<a class="tr-study-link" href="https://medlineplus.gov/genetics/condition/head-and-neck-squamous-cell-carcinoma" onclick="openNewWindow('https://medlineplus.gov/genetics/condition/head-and-neck-squamous-cell-carcinoma'); return false" style="margin-left:0.5em;" title="Head and neck squamous cell carcinoma at Genetics Home Reference">Head and neck squamous cell carcinoma</a>
</div>
<!-- SIS links -->
<div style="margin-bottom:2ex;">
<a class="tr-study-link" href="https://druginfo.nlm.nih.gov/drugportal" onclick="openNewWindow('https://druginfo.nlm.nih.gov/drugportal'); return false" title="Drug Information Portal">Drug Information</a> available for:
    	    	    	<a class="tr-study-link" href="https://druginfo.nlm.nih.gov/drugportal/name/Fluorouracil" onclick="openNewWindow('https://druginfo.nlm.nih.gov/drugportal/name/Fluorouracil'); return false" style="margin-left:0.5em;" title="Fluorouracil at Drug Information Portal">Fluorouracil</a>
<a class="tr-study-link" href="https://druginfo.nlm.nih.gov/drugportal/name/Cisplatin" onclick="openNewWindow('https://druginfo.nlm.nih.gov/drugportal/name/Cisplatin'); return false" style="margin-left:0.5em;" title="Cisplatin at Drug Information Portal">Cisplatin</a>
<a class="tr-study-link" href="https://druginfo.nlm.nih.gov/drugportal/name/Pembrolizumab" onclick="openNewWindow('https://druginfo.nlm.nih.gov/drugportal/name/Pembrolizumab'); return false" style="margin-left:0.5em;" title="Pembrolizumab at Drug Information Portal">Pembrolizumab</a>
</div>
<!-- Ropr Link -->
<!-- Commented out RoPR
  -->
<div style="margin-bottom:2ex;">
<a class="tr-study-link" href="/ct2/info/fdalinks" onclick="openNewWindow('/ct2/info/fdalinks'); return false" title="Show FDA resources page">U.S. FDA Resources</a>
</div>
</div>
</div>
<br/>
</div>
<!-- arms and groups table -->
<div class="tr-subsection">
<div class="ct-header2"><a id="armgroup"></a>Arms and Interventions</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Go to 
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="#wrapper">Top of Page</a>
<a href="#studydesc">Study Description</a>
<a href="#studydesign">Study Design</a>
<!-- arms and groups table -->
<a href="#armgroup">Arms and Interventions</a>
<a href="#outcomemeasures">Outcome Measures</a>
<a href="#eligibility">Eligibility Criteria</a>
<a href="#contactlocation">Contacts and Locations</a>
<a href="#moreinfo">More Information</a>
</div>
</div>
</div>
<div style="padding-left:.8em; padding-right:1.2em;text-align:left;">
<p>
</p><table class="ct-data_table tr-data_table" style="padding:5px;width:100%;border-width:1px;">
<thead>
<tr style="text-align:left;">
<th class="ct-header3 tr-pale_banner_color" style="width:50%;">
<span class="term" data-term="Arm" style="display:inline;" title="Show definition">Arm <i aria-hidden="true" class="fa fa-info-circle term" data-term="Arm" style="border-bottom-style:none;"></i></span> </th>
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="Intervention/treatment" style="display:inline;" title="Show definition">Intervention/treatment <i aria-hidden="true" class="fa fa-info-circle term" data-term="Intervention/treatment" style="border-bottom-style:none;"></i></span> </th>
</tr>
</thead>
<tbody>
<tr style="text-align:left;vertical-align:top;">
<td class="ct-body3">
          Experimental: pembrolizumab+cisplatin + 5-fluorouracil
<div class="tr-indent2" style="margin-top:0.5ex">pembrolizumab+cisplatin + 5-fluorouracil</div>
</td>
<td class="ct-body3">
                      Drug: pembrolizumab+cisplatin + 5-fluorouracil
<div class="tr-indent2" style="margin-top:0.5ex">ivgtt, pembrolizumab 200mg d1+cisplatin20 mg/m2 qd d1-d3 + 5-fluorouracil 3000mg/m last for 120hours , six circles</div><br/>
</td>
</tr>
</tbody>
</table>
</div>
<br/>
<!-- more details -->
<br/>
<div class="tr-subsection">
<div class="ct-header2"><a id="outcomemeasures"></a>Outcome Measures</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Go to 
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="#wrapper">Top of Page</a>
<a href="#studydesc">Study Description</a>
<a href="#studydesign">Study Design</a>
<!-- arms and groups table -->
<a href="#armgroup">Arms and Interventions</a>
<a href="#outcomemeasures">Outcome Measures</a>
<a href="#eligibility">Eligibility Criteria</a>
<a href="#contactlocation">Contacts and Locations</a>
<a href="#moreinfo">More Information</a>
</div>
</div>
</div>
<br/>
<div class="tr-indent3" style="margin-right:1em;">
<!-- primary outcomes -->
<div class="ct-body3">
<span class="term" data-term="Primary Outcome Measure" style="display:inline;" title="Show definition">Primary Outcome Measures <i aria-hidden="true" class="fa fa-info-circle term" data-term="Primary Outcome Measure" style="border-bottom-style:none;"></i></span> :
      <ol style="margin-top:1ex; margin-bottom:1ex;">
<li style="margin-top:0.7ex;">Primary site CR rate after neoadjuvant therapy [ Time Frame: Up to 6 months ]<div class="tr-indent2" style="margin-top:1ex;">Measure the primary site CR rate after neoadjuvant therapy</div><br/>
</li></ol>
</div>
<br/>
<!-- secondary outcomes -->
<div class="ct-body3" style="margin-right:1em;">
<span class="term" data-term="Secondary Outcome Measure" style="display:inline;" title="Show definition">Secondary Outcome Measures <i aria-hidden="true" class="fa fa-info-circle term" data-term="Secondary Outcome Measure" style="border-bottom-style:none;"></i></span> :
      <ol style="margin-top:1ex; margin-bottom:1ex;">
<li style="margin-top:0.7ex;">pfs [ Time Frame: up to 2 years ]<div class="tr-indent2" style="margin-top:1ex;">progression-free survival of all patients</div><br/>
</li><li style="margin-top:0.7ex;">dfs [ Time Frame: up to 2 years ]<div class="tr-indent2" style="margin-top:1ex;">disease free survival of all patients</div><br/>
</li><li style="margin-top:0.7ex;">Descending stage of tumor [ Time Frame: up to 6 months ]<div class="tr-indent2" style="margin-top:1ex;">Descending stage of primary lesion</div><br/>
</li><li style="margin-top:0.7ex;">One year local control rate [ Time Frame: up to 6 months ]<div class="tr-indent2" style="margin-top:1ex;">One year local control rate</div><br/>
</li><li style="margin-top:0.7ex;">Incidence of adverse reactions [ Time Frame: up to 2 years ]<div class="tr-indent2" style="margin-top:1ex;">safety of neoadjuvant therapy</div><br/>
</li><li style="margin-top:0.7ex;">OS [ Time Frame: 2 years ]<div class="tr-indent2" style="margin-top:1ex;">survival rates</div><br/>
</li></ol>
</div>
<br/>
</div>
<!-- eligibility_section -->
<div class="tr-indent1" style="margin-top:3ex; border:1px solid white">
<div class="tr-subsection">
<div class="ct-header2"><a id="eligibility"></a>Eligibility Criteria</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Go to 
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="#wrapper">Top of Page</a>
<a href="#studydesc">Study Description</a>
<a href="#studydesign">Study Design</a>
<!-- arms and groups table -->
<a href="#armgroup">Arms and Interventions</a>
<a href="#outcomemeasures">Outcome Measures</a>
<a href="#eligibility">Eligibility Criteria</a>
<a href="#contactlocation">Contacts and Locations</a>
<a href="#moreinfo">More Information</a>
</div>
</div>
</div>
<br/>
<p>
</p><div class="tr-indent2 usa-alert usa-alert-warning nlm-info">
<strong>Information from the National Library of Medicine</strong>
<img alt="" src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;"/>
<p>
</p><p>
<em>Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, <a href="/ct2/about-studies/learn" title="Learn About Clinical Studies"><u>Learn About Clinical Studies.</u></a>
</em>
</p></div>
<br/>
<div class="tr-indent2">
<table class="ct-layout_table tr-tableStyle tr-studyInfo">
<caption>Layout table for eligibility information</caption>
<thead>
<tr>
<th id="elgType"></th>
<th id="elgData"></th>
</tr>
</thead>
<tbody>
<tr>
<td class="ct-nowrap" headers="elgType">Ages Eligible for Study:   </td>
<td headers="elgData" style="padding-left:1em">18 Years to 85 Years   (Adult, Older Adult)</td>
</tr>
<tr>
<td class="ct-nowrap" headers="elgType">Sexes Eligible for Study:   </td>
<td headers="elgData" style="padding-left:1em">All</td>
</tr>
<tr>
<td class="ct-nowrap" headers="elgType">Accepts Healthy Volunteers:   </td>
<td headers="elgData" style="padding-left:1em">No</td>
</tr>
</tbody>
</table>
<div class="ct-header3" style="margin-top:2ex">Criteria</div>
<div class="tr-indent2"><p style="margin-top:1ex; margin-bottom:1ex;">Inclusion Criteria:</p>
<ul style="margin-top:1ex; margin-bottom:1ex;">
<li style="margin-top:0.7ex;">Age ≥ 18 years old, ≤ 85 years old Histologically or cytologically proven squamous cell carcinoma of the head and neck.Primary tumor sites eligible: oral cavity, oropharynx, hypopharynx. Although they are admittedly of squamous cell types, the following tumors will be excluded because of theY responsiveness to chemotherapy: tumors of the nasal and paranasal cavities, larynx and of the nasopharynx.</li>
</ul>
<p style="margin-top:0ex; margin-bottom:1ex;">At least one measurable lesion. No previous chemotherapy, radiotherapy or surgery (other than biopsy) for SSCHN.</p>
<p style="margin-top:0ex; margin-bottom:1ex;">ECOG performance status of 0 or 1. Life expectancy of greater than 12 weeks. Adequate bone marrow, hepatic and renal functions. Patients must be available for treatment and follow-up.</p>
<p style="margin-top:0ex; margin-bottom:1ex;">Exclusion Criteria:</p>
<ul style="margin-top:1ex; margin-bottom:1ex;">
<li style="margin-top:0.7ex;">Patients with multiple organs failure. SCCHN with distant metastases. Current severe, uncontrolled systemic disease. Mental illness. peripheral neuropathy with CTCAE V5.0 ≥ level 2. History of severe (Grade 3 or 4) allergic or hypersensitivity reaction to therapeutic antibodies that required discontinuation of therapy.</li>
</ul>
<p style="margin-top:0ex; margin-bottom:1ex;">Malignancies other than SCCHN within 5 years prior to enrollment. Nasopharyngeal cancer. Pregnant or lactating women.</p></div>
</div>
</div>
<!-- location_section -->
<a id="contacts"></a>
<div class="tr-indent1" style="margin-top:3ex">
<div class="tr-subsection">
<div class="ct-header2"><a id="contactlocation"></a>Contacts and Locations</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Go to 
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="#wrapper">Top of Page</a>
<a href="#studydesc">Study Description</a>
<a href="#studydesign">Study Design</a>
<!-- arms and groups table -->
<a href="#armgroup">Arms and Interventions</a>
<a href="#outcomemeasures">Outcome Measures</a>
<a href="#eligibility">Eligibility Criteria</a>
<a href="#contactlocation">Contacts and Locations</a>
<a href="#moreinfo">More Information</a>
</div>
</div>
</div>
<br/>
<div class="tr-indent2" style="margin-top:2ex">
<!--
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. 
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. 
For general information, see <a href="/ct2/about-studies/learn" target="def_win" onClick="openNewWindow('/ct2/about-studies/learn'); return false;" title="Learn About Clinical Studies - opens new window"><u>Learn About Clinical Studies.</u></a>
<br/>
-->
<div class="usa-alert usa-alert-warning nlm-info">
<strong>Information from the National Library of Medicine</strong>
<img alt="" src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;"/>
<p>
</p><p>
<em>
    To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
    </em>
</p><p>
<em>
    Please refer to this study by its ClinicalTrials.gov identifier (NCT number): <strong>NCT05446467</strong>
</em>
</p></div>
<br/>
<!-- contacts -->
<div class="ct-header3" style="margin-top:2ex">Contacts</div>
<div class="tr-table_cover">
<table class="ct-layout_table tr-indent2">
<caption>Layout table for location contacts</caption>
<thead>
<tr>
<th id="contactName" style="visibility:hidden"></th>
<th id="contactPhone" style="visibility:hidden"></th>
<th id="contactEmail" style="visibility:hidden"></th>
<th id="contactAddress" style="visibility:hidden"></th>
</tr>
</thead>
<tr>
<td headers="contactName">Contact: Xiao Ye, PhD</td>
<td headers="contactPhone">+86 18258107007</td>
<td headers="contactEmail"><a href="mailto:semper_fi%40foxmail.com?subject=NCT05446467, KPF20220630, Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC">semper_fi@foxmail.com</a></td>
<td headers="contactAddress"></td>
</tr>
</table>
</div>
<br/>
<!-- locations -->
<!-- sponsors -->
<div class="ct-header3" style="margin-top:2ex">Sponsors and Collaborators</div>
<div class="tr-indent2" style="margin-top:1ex">Zhejiang Provincial People's Hospital</div>
<!-- overall officials -->
<div class="ct-header3" style="margin-top:2ex">Investigators</div>
<div class="tr-table_cover">
<table class="ct-layout_table tr-indent2">
<caption>Layout table for investigator information</caption>
<thead>
<tr>
<th id="role" style="visibility:hidden"></th>
<th id="name" style="visibility:hidden"></th>
<th id="affiliation" style="visibility:hidden"></th>
<th id="address" style="visibility:hidden"></th>
</tr>
</thead>
<tr>
<td headers="role">Principal Investigator:</td>
<td headers="name">Minghua Ge, PhD</td>
<td headers="affiliation">Zhejiang Provincial People's Hospital</td>
<td headers="address"></td>
</tr>
</table>
</div>
</div>
</div>
<!-- more_info_section -->
<!-- Large docs section -->
<!-- More info section -->
<div class="tr-indent1" style="margin-top:3ex; border:1px solid white">
<div class="tr-subsection">
<div class="ct-header2"><a id="moreinfo"></a>More Information</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Go to 
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="#wrapper">Top of Page</a>
<a href="#studydesc">Study Description</a>
<a href="#studydesign">Study Design</a>
<!-- arms and groups table -->
<a href="#armgroup">Arms and Interventions</a>
<a href="#outcomemeasures">Outcome Measures</a>
<a href="#eligibility">Eligibility Criteria</a>
<a href="#contactlocation">Contacts and Locations</a>
<a href="#moreinfo">More Information</a>
</div>
</div>
</div>
<div class="tr-indent2" style="margin-top:1em;">
<!-- Additional Information -->
<!-- Available Study Data/Document -->
<!-- References -->
<!-- Derived References -->
<table class="ct-layout_table tr-tableStyle tr-moreInfo" style="margin-top:1ex;">
<caption>Layout table for additonal information</caption>
<thead>
<tr>
<th id="colTitle1"></th>
<th id="colData1"></th>
</tr>
</thead>
<tbody>
<tr>
<td class="ct-nowrap" headers="colTitle1">Responsible Party:</td>
<td headers="colData1" style="padding-left:1em">Minghua Ge, MD, Zhejiang Provincial People's Hospital</td>
</tr>
<tr>
<td class="ct-nowrap" headers="colTitle1">ClinicalTrials.gov Identifier:</td>
<td headers="colData1" style="padding-left:1em">
<a class="tr-study-link" href="https://clinicaltrials.gov/show/NCT05446467" title="Current version of study NCT05446467 on ClinicalTrials.gov">NCT05446467</a>    

  <script type="text/javascript">
    <!--
    // Scramble access to archive site -
    // don't want crawlers directing users to outdated versions of the study
    // this should be opaque to crawlers that don't execute javascript
    var yyy=new Array(
      ['<','a clas','s="tr-study','-link c', 't-now','rap" t','itle="Hist','orical vers','ions of '],
      ['study ','NCT05446467',' on Clin','icalTrials.','go'],
      ['v Ar','chive',' Sit','e" ','onc','lick="','openN','ewWin', 'dow(','\'/ct2/', 'history/'],
      ['NCT05446467','\'); return', ' false;" '],
      ['href','="/ct2/','history/','NCT05446467"','>'],
      ['Histo','ry of C','hange','s<','/','a>']);
    var i=0;
    var j=0;
    var xxx='';
    for (i=0; i<yyy.length; i++)
      for (j=0; j<yyy[i].length; j++)
        xxx+=yyy[i][j];
    document.write(xxx)
    -->
  </script>
</td>
</tr>
<tr>
<td class="ct-nowrap" headers="colTitle1">Other Study ID Numbers:</td>
<td headers="colData1" style="padding-left:1em">
                                    KPF20220630 <br/>
</td>
</tr>
<tr>
<td class="ct-nowrap" headers="colTitle1">First Posted:</td>
<td headers="colData1" style="padding-left:1em">July 6, 2022
            
          <a class="tr-study-link ct-nowrap" href="/ct2/keydates/NCT05446467" onclick="openNewWindow('/ct2/keydates/NCT05446467'); return false;" title="View key record dates for NCT05446467">Key Record Dates</a>
</td>
</tr>
<tr>
<td class="ct-nowrap" headers="colTitle1">Last Update Posted:</td>
<td headers="colData1" style="padding-left:1em">July 6, 2022
      </td>
</tr>
<tr>
<td class="ct-nowrap" headers="colTitle1">Last Verified:</td>
<td headers="colData1" style="padding-left:1em">June 2022
      </td>
</tr>
<!-- Plan to Share Data -->
</tbody>
</table>
<br/>
<table class="ct-layout_table tr-tableStyle tr-moreInfo" style="margin-top:1ex">
<caption>Layout table for additional information</caption>
<thead>
<tr>
<th id="colTitle2"></th>
<th id="colData2"></th>
</tr>
</thead>
<tbody>
<tr>
<td class="ct-nowrap" headers="colTitle2">Studies a U.S. FDA-regulated Drug Product:</td>
<td headers="colData2" style="padding-left:1em">Yes</td>
</tr>
<tr>
<td class="ct-nowrap" headers="colTitle2">Studies a U.S. FDA-regulated Device Product:</td>
<td headers="colData2" style="padding-left:1em">No</td>
</tr>
<tr>
<td class="ct-nowrap" headers="colTitle2">Product Manufactured in and Exported from the U.S.:</td>
<td headers="colData2" style="padding-left:1em">Yes</td>
</tr>
</tbody>
</table>
<!-- keywords -->
<!-- mesh terms -->
<div class="tr-tableLabel">Additional relevant MeSH terms:</div>
<div class="tr-indent3">
<table class="ct-layout_table tr-meshTerms" style="width:100%;">
<caption>Layout table for MeSH terms</caption>
<thead>
<tr>
<th id="meshTermCol1" style="width:50%;"></th>
<th id="meshTermCol2"></th>
</tr>
</thead>
<tr>
<td headers="meshTermCol1" style="padding-left:1em;">
                            Carcinoma<br/>
                            Carcinoma, Squamous Cell<br/>
                            Squamous Cell Carcinoma of Head and Neck<br/>
                            Neoplasms, Glandular and Epithelial<br/>
                            Neoplasms by Histologic Type<br/>
                            Neoplasms<br/>
                            Neoplasms, Squamous Cell<br/>
                            Head and Neck Neoplasms<br/>
                            Neoplasms by Site<br/>
                            Pembrolizumab<br/>
</td>
<td headers="meshTermCol1" style="padding-left:1em;">
                            Fluorouracil<br/>
                            Antineoplastic Agents<br/>
                            Antineoplastic Agents, Immunological<br/>
                            Antimetabolites<br/>
                            Molecular Mechanisms of Pharmacological Action<br/>
                            Antimetabolites, Antineoplastic<br/>
                            Immunosuppressive Agents<br/>
                            Immunologic Factors<br/>
                            Physiological Effects of Drugs<br/>
</td>
</tr>
</table>
</div>
<br/>
<!--
        <span class="ct-body3">ClinicalTrials.gov processed this record on July 11, 2022</span><br/>
      -->
<br/>
</div>
</div>
<div id="to-top"><a href="#wrapper">To Top</a></div>
<div style="clear:both;"></div>
</div>
</div>
</div></div>
</div>
{% endblock %}